Homocysteine and neurologic disease

Archives of Neurology

Volumn 57, Issue 10, 2000, Pages 1422-1428

  Diaz Arrastia, Ramon ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; CEREBROVASCULAR DISEASE; DEGENERATIVE DISEASE; DRUG EFFICACY; DRUG TOLERABILITY; EPILEPSY; HUMAN; HYPERHOMOCYSTEINEMIA; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE; TERATOGENICITY; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 0033776352     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.57.10.1422     Document Type: Review

References (70)

1. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis
2. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
3. Hyperhomocysteinemia and low pyridoxal phosphate: Common and independent reversible risk factors for coronary artery disease
4. 6, pyridoxal phosphate, and folate
5. Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
6. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: The Framingham study
7. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis
8. Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people
9. Homocysteine in cerebral macroangiography and microangiopathy
10. 12, and serum total homocysteine levels in confirmed Alzheimer disease
11. Total serum homocysteine in senile dementia of Alzheimer type
12. Identification of cognitive impairment in the elderly: Homocysteine is an early marker
13. The pathogenesis of homocysteinemia: Interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and trans-sulfuration of homocysteine
14. Homocysteine and other thiols in plasma and urine: Automated determination and sample stability
15. Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: Initial results from the NHLBI family heart study
16. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
17. Hyperhomocysteinemia: An independent risk factor for vascular disease
18. Reduction of plasma homocysteine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease
19. The effect of folic acid fortification on plasma folate and total homocysteine concentrations
20. Serum total homocysteine concentrations in adolescent and adult Americans: Results from the third National Nealth and Nutrition Examination Survey
21. Plasma homocysteine and cardiovascular risk profile: The Hordaland homocysteine study
22. Total homocysteine in plasma and amniotic fluid of pregnant women
23. Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women
24. Excess prevalence of fasting and postmethionine-loading hype rhomocysteinemia in stable renal transplant recipients
25. Associalion of dietary protein intake and coffee consumption with serum homocysteine concentrations in an older population
26. Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy
27. Plasma homocysteine and cardiovascular disease
28. Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer
29. Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants
30. Elevated plasma concentrations of homocysteine in antiepileptic drug treatment
31. Homocysteine and thrombotic disease
32. Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency
33. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians
34. Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease
35. Homocysteine and atherothrombosis
36. Homocysteine and vascular disease
37. Homocysteine as a risk factor for ischemic stroke: An epidemiological story in evolution
38. Hyperhomocysteinemia and thrombosis: Acquired conditions
39. Features, symptoms, and neurophysiological findings in stroke associated with hyperhomocysteinemia
40. Oxidative stress, glutamate, and neurodegenerative disorders
41. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor
42. 12, and neuropsychiatric disorders
43. Lowering blood homocysteine with folic acid based supplements meta-analysis of randomised trials BMJ
44. How safe are folic acid supplements?
45. 12 in Alzheimer-type dementia
46. 12 deficiency, malabsorbtion, and malnutrition
47. 12 and folate concentrations in serum and cerebrospinal fluid of neurological patients with special reference to multiple sclerosis and dementia
48. Low serum cobalamin levels in primary degenerative dementia: Do some patients harbor atypical cobalamin deficiency states?
49. Hyperhomocysteinemia: A common finding in a psychogeriatric population
50. Association between nutritional status and cognitive functioning in a healthy elderly population
51. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the normative aging study
52. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: Findings from the nun study
53. Elevated plasma levels of homocysteine in Parkinson's disease
54. Nigral endothelial dysfunction, homocysteine, and Parkinson's disease
55. Selective inhibition of homocysteine-induced seizures by glutamic acid diethyl ester and other glutamate esters
56. Seizures induced by homocysteine in rats during ontogenesis
57. The natural history of homocystinuria due to cystathionine beta-synthase deficiency
58. N-methyl-D-aspartate receptors and CNS symptoms of homocystinuria
59. Effect of long-term treatment with antiepileptic drugs on vitamin status
60. Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy
61. Guidelines for the care of women with epilepsy
62. Mechanisms of teratogenesis: Folic acid and antiepileptic therapy
63. The methoxyfolate axis in neural tube defects: In vitro characterisation and clinical investigation
64. Folic acid metabolism and mechanisms of neural tube defects
65. Maternal hyperhomocysteinemia: A risk factor for neural tube defects?
66. Homocysteine metabolism in pregnancies complicated by neural tube defects
67. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida
68. A genetic defect in 5,10 methylene-tetrahydrofolate reductase in neural tube defects
69. Neural tube defects and elevated homocysteine levels in amniotic fluid